New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

What steps can researchers take to combat crop viruses? This is what a recent study published in Nucleic Acids Research hopes to address as a team of resea | Plants And Animals ...

A research team led by Rice University's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1, a ...

KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the ...

Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical ...

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive ...

The report delivers a comprehensive analysis of global biologics sales. Covering cancer antibodies, non-TNF inflammatory mAbs, biosimilars, gene therapy, RNA-based drugs, and more, the report provides ...

Now the company she co-founded, RNhale, has been awarded a lucrative grant by the European Innovation Council (EIC).The young ...

Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...